Carbohydrate-based synthetic approach to control toxicity profiles of folate-drug conjugates.
Carbohydrate-based synthetic approach to control toxicity profiles of folate-drug conjugates.
复制标题
DOI:
10.1021/jo100448q
复制
发表时间:
2010-04
期刊:
影响因子:
--
通讯作者:
I. Vlahov;H. Santhapuram;Fei You;Yu Wang;Paul J. Kleindl;Spencer J. Hahn;Jeremy F. Vaughn;Daniel S. Reno;C. Leamon
中科院分区:
文献类型:
--
作者:
I. Vlahov;H. Santhapuram;Fei You;Yu Wang;Paul J. Kleindl;Spencer J. Hahn;Jeremy F. Vaughn;Daniel S. Reno;C. Leamon
To better regulate the biodistribution of the vinblastine-folate conjugate, EC145, a new folate-spacer that incorporates 1-amino-1-deoxy-D-glucitol-gamma-glutamate subunits into a peptidic backbone, was synthesized. Synthesis of Fmoc-3,4;5,6-di-O-isopropylidene-1-amino-1-deoxy-D-glucitol-gamma-glutamate 20, suitable for Fmoc-strategy solid-phase peptide synthesis (SPPS), was achieved in four steps from delta-gluconolactone. Addition of alternating glutamic acid and 20 moieties onto a cysteine-loaded resin, followed by the addition of folate, deprotection, and cleavage, resulted in the isolation of the new folate-spacer: Pte-gammaGlu-(Glu(1-amino-1-deoxy-D-glucitol)-Glu)(2)-Glu(1-amino-1-deoxy-D-glucitol)-Cys-OH (21). The addition of 21 to an appropriately modified desacetylvinblastine hydrazide (DAVLBH) resulted in a conjugate (25) with an improved therapeutic index. Treatment of 25 with DTT in neutral buffer at room temperature demonstrated that free DAVLBH would be released under the reductive environment of the internalized endosome.